Medium/long term effect of travoprost on the intraocular pressure (IOP) in normal tension glaucoma (NTG)

ISRCTN ISRCTN53835788
DOI https://doi.org/10.1186/ISRCTN53835788
Secondary identifying numbers N0547147995
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
03/06/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr G.S. Ang
Scientific

Senior House Officer
Department of Ophthalmology
Norfolk and Norwich University Hospital NHS Trust
Colney
Norwich
NR4 7UY
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesTravoprost is a new prostaglandin analogue recently approved for treatment of ocular hypertension and glaucoma.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEye Diseases: Glaucoma
InterventionProspective randomised controlled observer blinded clinical trial.
Intervention typeOther
Primary outcome measureThe primary clinical outcome measure is diurnal IOP at follow up phasing: the major comparison is to be made between the IOP for travoprost treatment group and for the non-treatment group.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/04/2004
Completion date01/06/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants25-30 patients
Key inclusion criteriaAdults with normal tension glaucoma.
Key exclusion criteria1. Patients on systemic medication
2. Patients who have undergone intraocular eye surgery
Date of first enrolment01/04/2004
Date of final enrolment01/06/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Senior House Officer
Norwich
NR4 7UY
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

East Norfolk and Waveney Research Consortium - Norfolk and Norwich University Hospital/Norwich PCT

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/08/2008 Yes No